Literature DB >> 26343106

Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions.

Chen Ling1,2, Yuan Wang3, Ying-lu Feng4, Ya-ni Zhang3, Jun Li3, Xin-rui Hu3,5, Li-na Wang3, Mao-feng Zhong5, Xiao-feng Zhai3, Irene Zolotukhin1, Arun Srivastava1,2, Chang-quan Ling3,6.   

Abstract

Recombinant adeno-associated virus (rAAV) serotype 2, 3 and 8 vectors are the most promising liver-tropic AAV serotype vectors. Liver diseases are significant problems in China. However, to date, few studies on AAV neutralizing antibodies (Nabs) were working with the Chinese population or with the rAAV3 vectors. The present study aimed to determine the prevalence of Nabs in Chinese population against wild-type AAV2, AAV3 and AAV8 capsids as well as additional two AAV3 variants. In addition, we performed a preliminary analysis to investigate the potential influence of traditional Chinese medicine body constitutions on AAV Nabs. Our work demonstrated that the majority of healthy Chinese subjects were positive for AAV Nabs, with the order of AAV2>AAV3=AAVLK03>AAV8. There was no difference between: 1) AAV3 and its variants; 2) male and female subjects; and 3) different age cohorts (≤35, 36-50, and ≥51 years old). People in the Qi-deficiency constitution had significantly increased AAV8 Nabs than people in the Gentleness constitution. Our studies may have impact on the future clinical design of AAV-based gene therapy in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26343106     DOI: 10.1016/S2095-4964(15)60200-X

Source DB:  PubMed          Journal:  J Integr Med


  12 in total

1.  Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.

Authors:  Shaoyong Li; Chen Ling; Li Zhong; Mengxin Li; Qin Su; Ran He; Qiushi Tang; Dale L Greiner; Leonard D Shultz; Michael A Brehm; Terence R Flotte; Christian Mueller; Arun Srivastava; Guangping Gao
Journal:  Mol Ther       Date:  2015-09-25       Impact factor: 11.454

2.  Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses.

Authors:  Chen Ling; Baozheng Li; Wenqin Ma; Arun Srivastava
Journal:  Hum Gene Ther Methods       Date:  2016-08       Impact factor: 2.396

3.  Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma.

Authors:  Min Li; Yuxiao Tang; Dongyao Wang; Xiaofeng Zhai; Hui Shen; Chen Zhong; Man Yao; Aiguo Jin; Zhengjun Zhou; Shaolai Zhou; Jia Fan; Chang-Quan Ling; Chen Ling
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 11.454

4.  Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.

Authors:  Nicole K Paulk; Katja Pekrun; Erhua Zhu; Sean Nygaard; Bin Li; Jianpeng Xu; Kirk Chu; Christian Leborgne; Allison P Dane; Annelise Haft; Yue Zhang; Feijie Zhang; Chris Morton; Marcus B Valentine; Andrew M Davidoff; Amit C Nathwani; Federico Mingozzi; Markus Grompe; Ian E Alexander; Leszek Lisowski; Mark A Kay
Journal:  Mol Ther       Date:  2017-09-25       Impact factor: 11.454

5.  Celastrol inhibits migration and invasion through blocking the NF-κB pathway in ovarian cancer cells.

Authors:  Zhongye Wang; Zhenyuan Zhai; Xiulan Du
Journal:  Exp Ther Med       Date:  2017-06-08       Impact factor: 2.447

6.  AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees.

Authors:  Roberto Calcedo; James M Wilson
Journal:  Hum Gene Ther Clin Dev       Date:  2016-06       Impact factor: 5.032

7.  Higher Seroprevalence of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies Among Racial Minorities in the United States.

Authors:  Arpana Khatri; Rajani Shelke; Shunjie Guan; Suryanarayan Somanathan
Journal:  Hum Gene Ther       Date:  2022-02-02       Impact factor: 5.695

8.  Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity.

Authors:  Tianzhuo Yao; Xueying Zhou; Chuanling Zhang; Xiaojuan Yu; Zhenyu Tian; Lihe Zhang; Demin Zhou
Journal:  Molecules       Date:  2017-07-11       Impact factor: 4.411

9.  Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort.

Authors:  Dany P Perocheau; Sharon Cunningham; Juhee Lee; Juan Antinao Diaz; Simon N Waddington; Kimberly Gilmour; Simon Eaglestone; Leszek Lisowski; Adrian J Thrasher; Ian E Alexander; Paul Gissen; Julien Baruteau
Journal:  Hum Gene Ther       Date:  2018-10-19       Impact factor: 5.695

10.  Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors.

Authors:  Chen Ling; Zifei Yin; Jun Li; Daniel Zhang; George Aslanidi; Arun Srivastava
Journal:  Mol Ther Methods Clin Dev       Date:  2016-05-04       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.